Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

Archives of General Psychiatry

Volumn 62, Issue 6, 2005, Pages 617-627

  Kessler, Ronald C ^a   Wai, Tat Chiu ^a   Demler, Olga ^a   Walters, Ellen E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; IMPULSE CONTROL DISORDER; INTERVIEW; MALE; MENTAL DISEASE; MOOD DISORDER; MULTIVARIATE ANALYSIS; PREVALENCE; REVIEW; SUBSTANCE ABUSE; WORLD HEALTH ORGANIZATION; ADDICTION; ADOLESCENT; ARTICLE; COMPARATIVE STUDY; HOSPITALIZATION; MAJOR DEPRESSION; MIDDLE AGED; PHOBIA; PSYCHOLOGICAL RATING SCALE; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH SURVEYS; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; PHOBIC DISORDERS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 20344374645     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.62.6.617     Document Type: Review

References (59)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B, Kessler RC, Norquist GS. Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Arch Gen Psychiatry. 1998;55:109-115.
3. Kessler RC, Wittchen H-U, Abelson JM, McGonagle KA, Schwarz N, Kendler KS, Knäuper B, Zhao S. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey. Int J Methods Psychiatr Res. 1998;7:33-55.
4. Kessler RC, Berglund PA, Bruce ML, Koch JR, Laska EM, Leaf PJ, Manderscheid RW, Rosenheck RA, Walters EE, Wang PS. The prevalence and correlates of untreated serious mental illness. Health Serv Res. 2001;36:987-1007.
5. Kessler RC, Zhao S, Katz SJ, Kouzis AC, Frank RG, Edlund M, Leaf P. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry. 1999;156:115-123.
6. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry. 2002;59:115-123.
7. Bijl RV, de Graaf R, Hiripi E, Kessler RC, Kohn R, Offord DR, Ustun TB, Vicente B, Vollebergh WA, Walters EE, Wittchen HU. The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood). 2003;22:122-133.
8. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, Polidori G, Kikkawa T, Kawakami N, Ono Y, Takeshima T, Uda H, Karam EG, Fayyad JA, Karam AN, Mneimneh ZN, Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang M, Alonso J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb C, Kessler RC, Merikangas KR, Anthony JC, Von Korff MR, Wang PS, Brugha TS, Aguilar-Gaxiola S, Lee S, Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S; WHO World Mental Health Survey Consortium. Prevalence, severity and unmet need for treatment of mental disorders in the World Health Organization World Mental Health surveys. JAMA. 2004;291:2581-2590.
9. Robins LN, Wing J, Wittchen H-U, Helzer JE. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069-1077.
10. Kessler RC, Ustun TB. The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13:93-121.
11. Kessler RC, Merikangas KR. The National Comorbidity Survey Replication (NCS-R): background and aims. Int J Methods Psychiatr Res. 2004;13:60-68.
12. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
13. Kessler RC, Berglund P, Chiu W-T, Demler O, Heeringa S, Hiripi E, Jin R, Pennell BE, Walters EE, Zaslavsky A, Zheng H. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004;13:69-92.
14. World Health Organization. International Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
16. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
17. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997;27:93-105.
18. Proctor BD, Dalaker J. Current population reports. In: Poverty in the United States: 2001. Washington, DC: US Government Printing Office; 2002.
19. US Census Bureau. County and City Databook, 2000. Washington, DC: US Government Printing Office; 2000.
20. Wolter KM. Introduction to Variance Estimation. New York, NY: Springer-Verlag; 1985.
21. SUDAAN. Professional Software for Survey Data Analysis. Version 8.0.1. Research Triangle Park, NC: Research Triangle Institute; 2002.
22. SAS Institute Inc. SAS/STAT Software: Changes and Enhancements, Release 8.2. Cary, NC: SAS Publishing; 2001.
23. McCutcheon AL, Mills C. Categorical data analysis: log-linear and latent class models. In: Scarbrough E, Tanenbaum E, eds. Research Strategies in the Social Sciences: a Guide to New Approaches. New York, NY: Oxford University Press; 1998:71-94.
24. Lazarsfeld PR, Henry NW. Latent Structure Analysis. Boston, Mass: Houghton-Mifflin; 1968.
25. Hagenaars JA, McCutcheon AL. Applied Latent Class Analysis. New York, NY: Cambridge University Press; 2002.
26. Numerical Approximation Group. Nag FORTRAN Library Introductory Guide. Downers Grove, Ill: Nag Inc; 1990.
27. Eaves LJ, Silberg JL, Hewitt JK, Rutter M, Meyer JM, Neale MC, Pickles A. Analyzing twin resemblance in multisymptom data: genetic applications of a latent class model for symptoms of conduct disorder in juvenile boys. Behav Genet. 1993;23:5-19.
28. Lewis SM, Raftery AE. Estimating Bayes factors via posterior simulation with the LaPlace-Metropolis estimator. J Am Stat Assoc. 1997;92:648-655.
29. Eaton WW, Anthony JC, Tepper S, Dryman A. Psychopathology and attrition in the Epidemiologic Catchment Area Study. Am J Epidemiol. 1992;135:1051-1059.
30. Allgulander C. Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study. Am J Public Health. 1989;79:1006-1010.
31. Kessler RC, Little RJA, Groves RM. Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiol Rev. 1995;17:192-204.
32. Cannell CF, Marquis KH, Laurent A. A summary of studies of interviewing methodology: 1959-1970 [National Center for Health Statistics Web site]. March 1977. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/series/sr02/100- 1/100-1.htm. Accessed April 15, 2005. Report 69.
33. Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280:867-873.
34. Bebbington PE, Nayani T. The psychosis screening questionnaire. Int J Methods Psychiatr Res. 1995;5:11-19.
35. Eaton WW, Romanoski A, Anthony JC, Nestadt G. Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis. 1991;179:689-693.
36. Spengler PA, Wittchen H-U. Procedural validity of standardized symptom questions for the assessment of psychotic symptoms: a comparison of the DIS with two clinical methods. Compr Psychiatry. 1988;29:309-322.
37. Keith SJ, Regier DA, Rae DS. Schizophrenic disorders. In: Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: Free Press; 1991:33-52.
38. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: the National Comorbidity Survey. Arch Gen Psychiatry. 1996;53:1022-1031.
39. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;420:21-27.
40. Posada Villa JA, Aguilar-Gaxiola S, Magana C, Gomez LC. Prevalencia de trastornos mentales u uso de servicios: resultados preliminares del Estudio Nacional de Salud Mental, Colombia, 2003. Revista Colombiana de Psiquiatria. 2004;33:241-262.
41. Olvera RL. Intermittent explosive disorder: epidemiology, diagnosis and management. CNS Drugs. 2002;16:517-526.
42. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60:837-844.
43. Lahey BB, Schwab-Stone M, Goodman SH, Waldman ID, Canino G, Rathouz PJ, Miller TL, Dennis KD, Bird H, Jensen PS. Age and gender differences in oppositional behavior and conduct problems: a cross-sectional household study of middle childhood and adolescence. J Abnorm Psychol. 2000;109:488-503.
44. Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am. 2000;9:541-555.
45. Pary R, Lewis S, Matuschka PR, Rudzinskiy P, Safi M, Lippmann S. Attention deficit disorder in adults. Ann Clin Psychiatry. 2002;14:105-111.
46. Kessler RC, Berglund PA, Zhao S, Leaf PJ, Kouzis AC, Bruce ML, Friedman RM, Grosser RC, Kennedy C, Kuehnel TG, Laska EM, Manderscheid RW, Narrow WE, Rosenheck RA, Santoni TW, Schneier M. The 12-month prevalence and correlates of serious mental illness (SMI). In: Manderscheid RW, Sonnenschein MA, eds. Mental Health, United States, 1996. Washington, DC: US Government Printing Office; 1996:59-70.
47. Kessler RC. Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohen M, Zahner GEP, eds. Textbook in Psychiatric Epidemiology. New York, NY: John Wiley & Sons; 1995:179-197.
48. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56:921-926.
49. Krueger RF, Chentsova-Dutton YE, Markon KE, Goldberg D, Ormel J. A cross-cultural study of the structure of comorbidity among common psychopathological syndromes in the general health care setting. J Abnorm Psychol. 2003;112:437-447.
50. Vollebergh WA, Iedema J, Bijl RV, de Graaf R, Smit F, Ormel J. The structure and stability of common mental disorders: the NEMESIS study. Arch Gen Psychiatry. 2001;58:597-603.
51. Kessler RC. The prevalence of psychiatric comorbidity. In: Wetzler S, Sanderson WC, eds. Treatment Strategies for Patients With Psychiatric Comorbidity. New York, NY: John Wiley & Sons; 1997.
52. Bland RC, Orn H, Newman SC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand. 1988;338:24-32.
53. Canino GJ, Bird HR, Shrout PE, Rubio-Stipec M, Bravo M, Martinez R, Sesman M, Guevara LM. The prevalence of specific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry. 1987;44:727-735.
54. Hwu HG, Yeh EK, Cheng LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese diagnostic interview schedule. Acta Psychiatr Scand. 1989;79:136-147.
55. Lee CK, Kwak YS, Yamamoto J, Rhee H, Kim YS, Han JH, Choi JO, Lee YH. Psychiatric epidemiology in Korea, part I: gender and age differences in Seoul. J Nerv Ment Dis. 1990;178:242-246.
56. Lépine JP, Lellouch J, Lovell A, Teherani M, Ha C, Verdier-Taillefer MH, Rambourg N, Lempérière T. Anxiety and depressive disorders in a French population: methodology and preliminary results. Psychiatry Psychobiology. 1989;4:267-274.
57. Wittchen H-U, Essau CA, von Zerssen D, Krieg CJ, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich Follow-up Study. Eur Arch Psychiatry Clin Neurosci. 1992;241:247-258.
58. Wells JE, Bushnell JA, Hornblow AR, Joyce PR, Oakley-Browne MA. Christchurch Psychiatric Epidemiology Study, part I: methodology and lifetime prevalence for specific psychiatric disorders. Aust N Z J Psychiatry. 1989;23:315-326.
59. Cross-national comparisons of the prevalences and correlates of mental disorders: WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ. 2000;78:413-426.